Unknown

Dataset Information

The cardiovascular risk of celecoxib for knee osteoarthritis: A protocol for systematic review and meta-analysis.


ABSTRACT:

Objective

The aim of this systematic review and meta-analysis is to assess the cardiovascular (CV) risk of celecoxib on knee osteoarthritis (KOA) patients compared with the risk in those prescribed other non-selective non-steroidal anti-inflammatory drugs (NSAIDs), no intervention or placebo-controlled patients.

Methods

The following databases will be searched: MEDLINE, EMBASE, the Cochrane Library, Web of Science, Chinese Biomedical Literature Database, Chinese Nation Knowledge Infrastructure, Wanfang Database, and the Chongqing VIP from inception to April 1, 2020. All randomized controlled trials (RCTs) of celecoxib that presented data on serious cardiovascular events among KOA patients will be included. Study selection, data extraction, quality assessment, and assessment

SUBMITTER: Cheng S 

PROVIDER: S-EPMC7440337 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature